A venture capital firm headquartered in the USA has invested over 160 startups in deep tech-focused areas such as SaaS, Biotech, AI chips, Fintech, Blockchain, and Semiconductors; with multiple unicorns in the firm’s portfolio. The firm recently closed its fourth fund, of $50M AUM, and is actively seeking investment opportunities across a wide range of industries. Within the Life Science area, the firm is interested in Therapeutics, Med Devices, Digital Health, and Diagnostics. The fund will focus on investing in the US or companies who are interested in entering the US market. On average, the typical size of investment is $0.5 – 1M but the firm also has follow-up investment strategies. The firm seeks to invest in early-stage companies, which Seed to Pre-A round is their sweet spot.
The firm is an opportunistic investor and will consider therapeutics, medical devices, diagnostics, and digital healthcare companies. The firm is open to a wide range of technologies including novel techniques. Within Medtech, The firm is strongly interested in robotics, semiconductors, sensors, AI modeling diseases, and telemedicine. The firm is open to novel medical devices of all FDA regulatory pathways, including 510k and PMA.
The firm has a preference for companies with a full-time founding team and was founded recently (no more than 10 years). The firm can act as either a lead investor or co-investor depends on applicable cases. If the firm acts as the lead investor, it will seek a board seat or an observer seat.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Next Phase Newsletter 
Leave a Reply